Insights

PTAB Grants Motion to Amend Claims, Kind Of, <i>PTAB Litigation Blog</i>

PTAB Grants Motion to Amend Claims, Kind Of, PTAB Litigation Blog

Visit the Jones Day PTAB Litigation Blog.

In Amerigen Pharmaceuticals Limited v. Shire LLC, IPR2015-02009 (March 31, 2017), the PTAB granted Shire’s Motion to Amend the claims in U.S. Reissued Patent RE 42,096, listed in the FDA’s Orange Book as covering Shire’s Adderall XR®.

Read the full article at ptablitigationblog.com

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.